Skip to content
PubMed This is a summary of 8 peer-reviewed journal articles Updated
Nephrology

Reading Your Pathology Report

At a Glance

A full-house kidney biopsy shows IgG, IgA, IgM, C3, and C1q deposits, but this pattern alone does not prove lupus. C1q intensity, deposit location, tubuloreticular inclusions, light microscopy, blood tests, and clinical findings must be interpreted together.

A kidney biopsy is like a high-resolution map of your kidney’s health. When your doctor says you have a “full-house” pattern, they are describing what they see when they look at your tissue through three different types of “lenses”: light, glowing dyes, and a high-powered electron beam [1]. Understanding these three sections of your pathology report can help you see why your diagnosis is called “idiopathic non-lupus” rather than Lupus Nephritis.

1. Immunofluorescence (The ‘Glow’ Test)

This is where the term full-house originates. The pathologist uses fluorescent dyes to see if certain immune proteins have deposited in your kidney’s filters (glomeruli). In a full-house result, all five of these markers light up at once:

  • IgG, IgA, IgM: Three types of antibodies.
  • C3 and C1q: Two types of “complement” proteins that help antibodies work [1].

The “Non-Lupus” Context: While Lupus patients often show a very strong (3+ or 4+) glow for C1q, people with idiopathic non-lupus full-house nephropathy frequently have much weaker C1q staining [2][3]. However, staining intensity overlaps. Trace or 1+ C1q does not definitively rule out Lupus, and intense C1q does not confirm it. Staining distribution and intensity provide context to a renal pathologist but cannot diagnose or exclude lupus on their own [2].

2. Electron Microscopy (The Deep Dive)

Electron Microscopy (EM) zooms in thousands of times to see exactly where immune deposits (called electron-dense deposits) are piling up.

  • Location Matters: Deposits can be in the mesangium (the kidney’s structural support), subepithelial (on the outside of the filter wall), or subendothelial (on the inside of the filter wall) [4].
  • The “Lupus Fingerprint”: Pathologists look for tubuloreticular inclusions (TRIs). These are tiny, coiled structures inside the cells that line your blood vessels. They are often triggered by a protein called interferon, which is very high in Lupus [5][6].
  • Why TRIs Matter to You: The presence or absence of these inclusions provides supportive contextual information. While they are a characteristic feature of Lupus, they are an interferon-associated, nonspecific finding. Their absence does not fully rule out Lupus, and they must be interpreted with serology and the rest of the biopsy [7].

3. Light Microscopy (The Big Picture)

Light microscopy (LM) looks at the overall “architecture” of the kidney damage. Idiopathic full-house disease spans multiple patterns, including:

  • Membranous Pattern: The filter walls are thickened [8].
  • Mesangial Pattern: The damage is mostly confined to the support structure of the filter [2].
  • Proliferative or Crescentic Patterns: Active inflammation with extra cell growth, which can cause substantial kidney injury [8].

Your Pathology Completeness Checklist

To ensure your diagnosis is as accurate as possible, your report should ideally contain detailed notes in these three areas, integrated by a pathologist:

Section What to Look For Why It Matters
Immunofluorescence Scores for IgG, IgA, IgM, C3, and C1q Confirms the “Full-House” pattern.
Electron Microscopy Mention of Tubuloreticular Inclusions (TRIs) Provides supportive context [7].
Electron Microscopy Location of deposits (e.g., Mesangial) Helps identify which “flavor” of kidney disease you have [4].
Light Microscopy The structural pattern (e.g., Membranous) Guides the overall treatment strategy [8].
Quantification Specimen Adequacy The pathologist determines if the sample was sufficient (the number of glomeruli needed is disease- and specimen-dependent).

If any of these pieces are missing, it is worth asking your doctor if a “second look” at the tissue or a specialized consultation with a renal pathologist through your treating team is needed [2].

Common questions in this guide

What does a full-house pattern mean on a kidney biopsy?
A full-house pattern means immunofluorescence detects IgG, IgA, IgM, C3, and C1q in the kidney's glomeruli, or filtering units. It can occur in lupus nephritis and in idiopathic non-lupus full-house nephropathy, so the pattern alone does not establish a diagnosis of lupus.
Can C1q staining tell whether I have lupus nephritis?
Idiopathic non-lupus cases often have weaker C1q staining, while lupus may show stronger staining, but the ranges overlap. A weak or strong C1q result cannot by itself rule out or confirm lupus; your clinician must consider the staining distribution, blood tests, and the rest of the biopsy.
What are tubuloreticular inclusions on electron microscopy?
Tubuloreticular inclusions are tiny coiled structures seen inside cells lining blood vessels on electron microscopy. They are often linked to interferon activity and can support a lupus-related interpretation, but they are not specific to lupus, and their absence does not rule lupus out.
Why does the location of immune deposits matter?
Electron microscopy can show whether deposits are in the mesangium, beneath the outer side of the filter, or beneath the inner side. Their location helps the renal pathologist classify the kidney injury and gives your care team context for treatment decisions, but it is not interpreted alone.
What can light microscopy show in a full-house nephropathy biopsy?
Light microscopy shows the kidney's overall structure and may identify membranous, mesangial, proliferative, or crescentic patterns. These patterns describe different types of filter thickening or inflammation and help the medical team discuss treatment.
What should a complete kidney biopsy pathology report include?
It should report the immunofluorescence results for IgG, IgA, IgM, C3, and C1q; electron microscopy findings such as deposit location and tubuloreticular inclusions; the light microscopy pattern; and whether the specimen was adequate. If information is missing, ask your treating team whether a renal pathologist should review the tissue.

Get notified when new evidence is published on Idiopathic non-lupus full-house nephropathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (8)
  1. 1

    Non-lupus full house nephropathy in pediatrics: Case reports

    Guerrero GA, Guerrero LF, González T

    Biomedica : revista del Instituto Nacional de Salud 2020; (40(2)):220-227 doi:10.7705/biomedica.4863.

    PMID: 32673451
  2. 2

    Idiopathic non-lupus full-house nephropathy is associated with poor renal outcome.

    Rijnink EC, Teng YK, Kraaij T, et al.

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2017; (32(4)):654-662 doi:10.1093/ndt/gfx020.

    PMID: 28340077
  3. 3

    Clinical and histopathological predictors of systemic lupus erythematosus in a South American cohort of patients with full-house glomerulonephritis.

    Tanten Zabaleta R, Espejo E, Scaglioni V, et al.

    Lupus 2026; (35(10)):1058-1065 doi:10.1177/09612033261463575.

    PMID: 42334098
  4. 4

    An Interesting Case of Nonlupus Full-House Nephropathy.

    Sathi S, Sharma A, Garg AK, et al.

    Case reports in nephrology 2021; (2021()):9043003 doi:10.1155/2021/9043003.

    PMID: 34992890
  5. 5

    Tubuloreticular Inclusions in the Absence of Systemic Lupus Erythematosus and HIV Infection: A Report of Three Pediatric Cases.

    Elmaghrabi A, Brown E, Khin E, et al.

    Case reports in nephrology and dialysis 2017; (7(2)):91-101 doi:10.1159/000477661.

    PMID: 28868299
  6. 6

    Anti-neutrophil cytoplasmic antibody associated glomerulonephritis complicating treatment with hydralazine.

    Santoriello D, Bomback AS, Kudose S, et al.

    Kidney international 2021; (100(2)):440-446 doi:10.1016/j.kint.2021.03.029.

    PMID: 33857570
  7. 7

    The spectrum of renal diseases with lupus-like features: a single-center study.

    Ahmed M, Love T, Moore C, et al.

    Renal failure 2022; (44(1)):581-593 doi:10.1080/0886022X.2022.2057862.

    PMID: 35357272
  8. 8

    Clinicopathological Pattern of Non-lupus Full House Nephropathy.

    Wani AS, Zahir Z, Gupta A, Agrawal V

    Indian journal of nephrology 2020; (30(5)):301-306 doi:10.4103/ijn.IJN_91_18.

    PMID: 33707816

This page is for informational purposes only and does not constitute medical advice. Your nephrologist and renal pathologist should interpret your biopsy findings and lupus evaluation in context.